Gc Cell Corp. (144510) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Gc Cell Corp. (144510:KRX), powered by AI.

Current Price
₩17,320
P/E Ratio
-1.0
Market Cap
273.7B
Sector
Healthcare
What is the Gc Cell Corp. stock price forecast?

Gc Cell Corp. is currently trading at ₩17,320. View real-time AI analysis on Alpha Lenz.

What is Gc Cell Corp. insider trading activity?

View the latest insider trading data for Gc Cell Corp. on Alpha Lenz.

What is Gc Cell Corp.'s P/E ratio?

Gc Cell Corp.'s P/E ratio is -1.0.

Gc Cell Corp.

KRX · 144510
₩17,320+490(+2.91%)Market closedKRX regular session 09:00–15:30 KST
Ask about Gc Cell Corp.'s future dividend policy...
Alpha Chat Insight

Gc Cell Corp. trades at a P/E of -1.0 (undervalued) with modest ROE of -84.7%.

Ask for details

Company Overview

Gc Cell Corp. is primarily a biotechnology company focused on the research, development, and commercialization of cell therapies. The company plays a pivotal role in advancing medicinal biotechnology, particularly through its innovative approaches to harnessing the therapeutic potential of cellular and genetic sciences. Gc Cell Corp.'s work is largely concentrated in creating cutting-edge treatments aimed at addressing a wide range of diseases, including those that are currently considered challenging to treat with conventional methods. By leveraging advancements in biotechnological processes, the company seeks to provide transformational therapies that can improve patient outcomes and healthcare solutions globally. Its impact is notably seen in sectors such as personalized medicine, cancer treatment, and regenerative medicine, where breakthroughs in cell-based technologies have the potential to revolutionize standard care practices. Gc Cell Corp.'s position in the market underscores its importance in the ongoing development of advanced therapeutic solutions, contributing to both industry innovation and increased accessibility to life-saving treatments.

CEO원성용, 김재왕
SectorHealthcare
IndustryDiagnostics & Research
Employees752

Company Statistics

FY 2025

Profile

₩273,661,958,080Market Cap
₩165,523,143,700Revenue
15.80MShares Out
752Employees

Margins

17.50%Gross
-4.63%EBITDA
-8.33%Operating
-163.83%Pre-Tax
-165.25%Net

Valuation

-1.00P/E
1.47P/B
1.65EV/Sales
-46.53EV/EBITDA
100.68P/FCF

Growth (CAGR)

-11.17%Rev 3Yr
14.11%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-62.02%ROA
-84.71%ROE
-60.41%ROIC

Financial Health

₩1,461,801,000Cash & Cash Equivalents
₩111,847,164,640Net Debt
59.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Gc Cell Corp. (ticker: 144510) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 752 employees. Market cap is $273.7B.

The current price is ₩17,320 with a P/E ratio of -1x and P/B of 1.47x.

ROE is -84.71% and operating margin is -8.33%. Annual revenue is $165.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Gc Cell Corp. (144510) Stock Forecast 2026 ₩17,320 — Price, Financials & Analyst Targets | Alpha Lenz